Corresponding to the DMSO group, we performed transient overexpression of BCLAF1-WT or BCLAF1-mSBC in SPOP-overexpressing HCC cell lines in the Atezolizumab group, respectively. The gene discussed is BCLAF1; the disease is hepatocellular carcinoma.